Pradžia › Židininis segmentinis glomerulosklerozė › Texas
Židininis segmentinis glomerulosklerozė klinikiniai tyrimai Texas
5 tyrimai dėl Židininis segmentinis glomerulosklerozė ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #5, Arlington
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
- ir dar 1
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo
- The Healing Kidneys Institute, Conroe
- Advanced Dallas Hospital and Clinics, Dallas
- ir dar 4
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Renkami dalyviai2 fazė
Amžius nuo 16 iki 75 · Visoms lytims · Atnaujinta 2026-09-23 · NCT06500702Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
Renkami dalyviaiStebimasis tyrimas
Iki 80 metų · Visoms lytims · Atnaujinta 2026-06-10 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
Renkami dalyviai2 fazė
Amžius nuo 1 iki 17 · Visoms lytims · Atnaujinta 2026-05-12 · NCT05003986Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.